The Age of Upcycling Is Here
January 30, 2024
We are witnessing a new era in primary packaging for pharmaceuticals
6 min read
COVID-19 continues to exert its effect on the world; we look at what lessons have been learned from the crisis and how Europe is planning manufacturing capacity for future emergencies. Sustainability is also a key topic for this issue with Vetter’s Henryk Badack giving his thoughts on how companies can be more energy efficient, and TekniPlex’s Michiel van den Berg discussing the packaging and recyclability. Also covered: the impact of gene therapies on diseases of the eye, enteric-coated suforaphanes, the labs of pharma’s future, and much more.
January 30, 2024
We are witnessing a new era in primary packaging for pharmaceuticals
6 min read
January 29, 2024
A look at the FDA’s investigation into CAR Ts
3 min read
January 19, 2024
With mRNA technology scooping the 2023 Nobel Prize for Medicine, demand is growing. Can CDMOs keep up?
4 min read
January 18, 2024
Labs of the future will use VR, AR, AI and more. But we must overcome the barriers of implementation, including cultural resistance.
4 min read
January 12, 2024
Three companies – Cardinal Health, REGENXBIO, and Beacon Therapeutics – help us explore gene therapy development in the ophthalmic space
13 min read
December 13, 2023
From renewable energy to bicycle schemes and more; here are just a few examples of how a pharma business can be more sustainable
10 min read
November 15, 2023
After serving as the Head of Strategic Research Development and Director of the Office of the Dean of Research at Trinity College Dublin, Fiona Killard-Lynch was appointed Director of Research and Innovation at NIBRT
6 min read
October 18, 2023
Sulforaphane has therapeutic potential in numerous areas but formulation is key. Can enteric coatings help find the way forward?
4 min read
March 6, 2023
Contact with the sharp end of reality eliminates our assumptions and exposes our weakness. Contact with COVID-19 has done the same for pharma and healthcare.
8 min read
False
False